title: Determinants of restrictive lung function in asbestos-induced pleural fibrosis.
abstract: We evaluated whether restrictive lung function among asbestos-exposed individuals with pleural fibrosis was caused by radiographically inapparent parenchymal inflammation and/or parenchymal fibrosis. All 24 study participants were sheet metal workers who were nonsmokers with normal parenchyma on posteroanterior chest radiograph. These subjects had either normal pleura (n = 7), circumscribed plaques (n = 9), or diffuse pleural thickening (n = 8). After controlling for age, years in the trade, and pack-years of smoking, we found that sheet metal workers with diffuse pleural thickening had a lower forced vital capacity (P less than 0.001), total lung capacity (P less than 0.01), and CO-diffusing capacity of the lung (P less than 0.05) than those with normal pleura. Similarly, sheet metal workers with circumscribed plaques were found to have a reduced forced vital capacity; however, because of the small number of study subjects, this difference (regression coefficient = -11.0) was only marginally significant (P = 0.06). Although circumscribed plaque and diffuse pleural thickening were both associated with a lymphocytic alveolitis and a higher prevalence of parenchymal fibrosis on high-resolution computerized tomography (HRCT) scan, neither a lymphocytic alveolitis nor the finding of parenchymal fibrosis on HRCT scan influenced the relationship between pleural fibrosis and restrictive lung function. We conclude that pleural fibrosis is associated with restrictive lung function and abnormally low diffusion that appears to be independent of our measures of parenchymal injury (chest X-ray, bronchoalveolar lavage, and HRCT scan).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Internal Medicine, University of Iowa, Iowa City 52242.
authors.forename: D A
authors.initials: DA
authors.lastname: Schwartz
authors.forename: J R
authors.initials: JR
authors.lastname: Galvin
authors.forename: C S
authors.initials: CS
authors.lastname: Dayton
authors.forename: W
authors.initials: W
authors.lastname: Stanford
authors.forename: J A
authors.initials: JA
authors.lastname: Merchant
authors.forename: G W
authors.initials: GW
authors.lastname: Hunninghake
mesh_terms: D000368:Aged; D001194:Asbestos / Q000009:adverse effects*; D001992:Bronchoalveolar Lavage Fluid / Q000473:pathology; D005355:Fibrosis; D006801:Humans; D008168:Lung / Q000503:physiopathology*; D008669:Metallurgy; D008875:Middle Aged; D009784:Occupational Diseases / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology; D010994:Pleura / Q000473:pathology*; D011653:Pulmonary Diffusing Capacity; D014057:Tomography, X-Ray Computed; D014109:Total Lung Capacity; D014797:Vital Capacity
chemical_list: D001194:Asbestos